Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- VISTN.OL
- Price
- 23.00
- Stock movement down
- -0.40 (-1.71%)
- Company name
- Vistin Pharma ASA
- Exchange
- (OL ,
- Currency
- NOK )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 1.02B
- Ent value
- 1.09B
- Price/Sales
- 2.41
- Price/Book
- 3.28
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 99.36%
- Trailing P/E
- 16.62
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -3.77%
- 3 year return
- 10.39%
- 5 year return
- 24.59%
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
VISTN.OL does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 16.62 |
| Price to OCF | 10.21 |
| Price to FCF | 18.29 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.41 |
| Price to Book | 3.28 |
| EV to Sales | 2.58 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 44.34M |
| EPS (TTM) | 1.38 |
| FCF per share (TTM) | 1.26 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 423.59M |
| Gross profit (TTM) | 218.13M |
| Operating income (TTM) | 82.67M |
| Net income (TTM) | 61.37M |
| EPS (TTM) | 1.38 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 51.50% |
| Operating margin (TTM) | 19.52% |
| Profit margin (TTM) | 14.49% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 5.63M |
| Net receivables | 61.28M |
| Total current assets | 143.82M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 387.94M |
| Accounts payable | 18.30M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 67.40M |
| Total liabilities | 77.20M |
| Shareholder's equity | 310.74M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 99.86M |
| Capital expenditures (TTM) | 44.09M |
| Free cash flow (TTM) | 55.77M |
| Dividends paid (TTM) | 55.41M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 19.75% |
| Return on Assets | 15.82% |
| Return on Invested Capital | 19.75% |
| Cash Return on Invested Capital | 17.95% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 23.40 |
| Daily high | 23.40 |
| Daily low | 23.00 |
| Daily Volume | 4K |
| All-time high | 28.60 |
| 1y analyst estimate | - |
| Beta | 0.89 |
| EPS (TTM) | 1.38 |
| Dividend per share | - |
| Ex-div date | 6 Nov 2024 |
| Next earnings date | 22 Apr 2025 |
Downside potential
Loading...
Downside potential data
| VISTN.OL | S&P500 | |
| Current price drop from All-time high | -19.58% | -12.89% |
| Highest price drop | -82.27% | -56.47% |
| Date of highest drop | 16 Mar 2020 | 9 Mar 2009 |
| Avg drop from high | -35.20% | -11.07% |
| Avg time to new high | 117 days | 12 days |
| Max time to new high | 2009 days | 1805 days |
COMPANY DETAILS
Marketcap
1.02B
Marketcap category
Small-cap
Description
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.
Employees
73
Website
Investor relations
-
SEC filings
CEO
Country
Norway
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Oslo, Norway, 13th of February 2025 Vistin Pharma ASA (VISTN) today announces the financial results for the fourth quarter and preliminary results of 2024. Revenue in the fourth quarter ended at MNOK ...
February 13, 2025
Oslo, Norway, 6 February 2025 Vistin Pharma ASA will release its fourth quarter and preliminary 2024 results on Thursday 13th of February 2025. Vistin Pharma will host a conference call for all shareh...
February 6, 2025
Oslo, Norway, 31st of October 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the third quarter of 2024. Revenue in the third quarter ended at MNOK 106 compared to MNOK 120 in...
October 31, 2024
Oslo, Norway, 24 October 2024 Vistin Pharma ASA will release its third quarter and YTD 2024 results on Thursday 31st of October 2024. Vistin Pharma will host a conference call for all shareholders and...
October 24, 2024
Oslo, Norway, 23rd of August 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the second quarter of 2024. Revenue in the second quarter ended at MNOK 106 compared to MNOK 107 i...
August 23, 2024
Oslo, Norway, 16 August 2024 Vistin Pharma ASA will release its second quarter and YTD 2024 results on Friday 23rd of August 2024. Vistin Pharma will host a conference call for all shareholders and in...
August 16, 2024
Oslo, Norway, 23 May 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held today, on the 23 May 2024. All matters were resolved as proposed in the ...
May 23, 2024
Oslo, Norway, 30 April 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 23 May 2024 at 13:00 CEST. A physical Annual Ge...
April 30, 2024
Oslo, Norway, 24th of April 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2024. Revenue in the first quarter ended at MNOK 104 compared to MNOK 101 in Q...
April 24, 2024
Oslo, Norway, 16 April 2024 Vistin Pharma ASA will release its first quarter results on Wednesday 24th of April 2024. Vistin Pharma will host a conference call for all shareholders and interested part...
April 16, 2024